Sign up to get updates from us
CMTA CEO Amy Grey and CMTA Chairman Gilles Bouchard get real and personal as they discuss the CMTA’s ongoing success as the #1 CMT organization globally. This multi-dimensional dynamic duo, with deep roots in the charitable foundation profession and tech industry, sheds light on how the CMTA, a small but efficient organization, is setting standards of excellence in the non-profit sector. With the backing of our community, CMT clinicians, world-renowned scientists, researchers, and an increasing number of pharma partners, the CMTA is changing the world at an accelerated pace. Listen and learn how our CMT patient community has inspired, motivated, and influenced the growth of the CMTA and its mission - to support the development of new drugs to treat CMT, to improve the quality of life for people with CMT, and, ultimately, to find a cure. Our vision … a world without CMT.
For more information about CMT and to support the CMTA, please visit www.cmtausa.org
